Hypoperfusion causes increased production of interleukin 6 and tumor necrosis factor alpha in the isolated, dually perfused placental cotyledon

Am J Obstet Gynecol. 2000 Oct;183(4):863-7. doi: 10.1067/mob.2000.108887.

Abstract

Objective: Our purpose was to determine whether exposure of the isolated, perfused human placental cotyledon to different fetal circuit perfusion rates, and to concomitant pressure differences, alters placental production of interleukin 6 and tumor necrosis factor alpha.

Study design: The maternal and fetal circulations of 2 cotyledons from 5 placentas were perfused for 4 hours. The fetal circulation of 1 cotyledon was perfused at a low rate of 1 mL/min, and the other at a high rate of 10 mL/min. The maternal circulation of each cotyledon was perfused at 10 mL/min. Effluents from the fetal circulation were collected at hourly intervals, and concentrations of interleukin 6 and tumor necrosis factor alpha were determined by enzyme-linked immunosorbent assay. Concentrations of interleukin 6, obtained from a prior study with an estimated physiologic fetal circulation rate of 4 mL/min, were compared with the low and high perfusion rate results.

Results: Concentrations of interleukin 6 and tumor necrosis factor alpha were greater at the perfusion rate of 1 mL/min, in comparison with the perfusion rate of 10 mL/min, with statistically significant differences achieved at 2 and 4 hours for interleukin 6 and at 4 hours for tumor necrosis factor alpha. Concentrations of both cytokines increased exponentially with time. Placental perfusion pressures were significantly greater at the perfusion rate of 10 mL/min.

Conclusion: Placental hypoperfusion results in an increased production of both interleukin 6 and tumor necrosis factor alpha. This finding links placental perfusion abnormalities to the myriad of disorders associated with elevated concentrations of inflammatory cytokines, including cerebral palsy.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Blood Circulation
  • Female
  • Fetus / physiology
  • Humans
  • In Vitro Techniques
  • Interleukin-6 / metabolism*
  • Osmolar Concentration
  • Perfusion* / methods
  • Placenta / blood supply*
  • Pregnancy
  • Pressure
  • Time Factors
  • Tumor Necrosis Factor-alpha / biosynthesis*

Substances

  • Interleukin-6
  • Tumor Necrosis Factor-alpha